These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 32579959)
1. Snake venom three-finger toxins and their potential in drug development targeting cardiovascular diseases. Kini RM; Koh CY Biochem Pharmacol; 2020 Nov; 181():114105. PubMed ID: 32579959 [TBL] [Abstract][Full Text] [Related]
2. Snake Venom Peptides and Low Mass Proteins: Molecular Tools and Therapeutic Agents. Almeida JR; Resende LM; Watanabe RK; Carregari VC; Huancahuire-Vega S; da S Caldeira CA; Coutinho-Neto A; Soares AM; Vale N; de C Gomes PA; Marangoni S; de A Calderon L; Da Silva SL Curr Med Chem; 2017; 24(30):3254-3282. PubMed ID: 27804880 [TBL] [Abstract][Full Text] [Related]
3. Snake Venom Components: Tools and Cures to Target Cardiovascular Diseases. Frangieh J; Rima M; Fajloun Z; Henrion D; Sabatier JM; Legros C; Mattei C Molecules; 2021 Apr; 26(8):. PubMed ID: 33921462 [TBL] [Abstract][Full Text] [Related]
4. Snake Venom: From Deadly Toxins to Life-saving Therapeutics. Waheed H; Moin SF; Choudhary MI Curr Med Chem; 2017; 24(17):1874-1891. PubMed ID: 28578650 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular-Active Venom Toxins: An Overview. Rebello Horta CC; Chatzaki M; Rezende BA; Magalhães Bde F; Duarte CG; Felicori LF; Ribeiro Oliveira-Mendes BB; do Carmo AO; Chávez-Olórtegui C; Kalapothakis E Curr Med Chem; 2016; 23(6):603-22. PubMed ID: 26812904 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Effects of Snake Toxins: Cardiotoxicity and Cardioprotection. Averin AS; Utkin YN Acta Naturae; 2021; 13(3):4-14. PubMed ID: 34707893 [TBL] [Abstract][Full Text] [Related]
13. From snake venom toxins to therapeutics--cardiovascular examples. Koh CY; Kini RM Toxicon; 2012 Mar; 59(4):497-506. PubMed ID: 21447352 [TBL] [Abstract][Full Text] [Related]
14. Proline rich-oligopeptides: diverse mechanisms for antihypertensive action. Morais KL; Ianzer D; Miranda JR; Melo RL; Guerreiro JR; Santos RA; Ulrich H; Lameu C Peptides; 2013 Oct; 48():124-33. PubMed ID: 23933300 [TBL] [Abstract][Full Text] [Related]
15. LmrBPP9: A synthetic bradykinin-potentiating peptide from Lachesis muta rhombeata venom that inhibits the angiotensin-converting enzyme activity in vitro and reduces the blood pressure of hypertensive rats. Pinheiro-Júnior EL; Boldrini-França J; de Campos Araújo LMP; Santos-Filho NA; Bendhack LM; Cilli EM; Arantes EC Peptides; 2018 Apr; 102():1-7. PubMed ID: 29410030 [TBL] [Abstract][Full Text] [Related]
16. Hypotensive agents from snake venoms. Joseph R; Pahari S; Hodgson WC; Kini RM Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):437-59. PubMed ID: 15578962 [TBL] [Abstract][Full Text] [Related]
17. Three-finger toxins from the venom of Micrurus tschudii tschudii (desert coral snake): Isolation and characterization of tschuditoxin-I. Lomonte B; Camacho E; Fernández J; Salas M; Zavaleta A Toxicon; 2019 Sep; 167():144-151. PubMed ID: 31211957 [TBL] [Abstract][Full Text] [Related]
18. An overview of the immune modulating effects of enzymatic toxins from snake venoms. Burin SM; Menaldo DL; Sampaio SV; Frantz FG; Castro FA Int J Biol Macromol; 2018 Apr; 109():664-671. PubMed ID: 29274419 [TBL] [Abstract][Full Text] [Related]
19. Snake venom derived molecules in tumor angiogenesis and its application in cancer therapy; an overview. Dhananjaya BL; Sivashankari PR Curr Top Med Chem; 2015; 15(7):649-57. PubMed ID: 25714377 [TBL] [Abstract][Full Text] [Related]
20. The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme. Hayashi MA; Murbach AF; Ianzer D; Portaro FC; Prezoto BC; Fernandes BL; Silveira PF; Silva CA; Pires RS; Britto LR; Dive V; Camargo AC J Neurochem; 2003 May; 85(4):969-77. PubMed ID: 12716428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]